These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 27646211)
21. Acquired hemophilia A: report of two cases. Chen YC; Chang JY; Hsueh EJ; Wan HL; Chao TY Zhonghua Yi Xue Za Zhi (Taipei); 1998 Sep; 61(9):538-44. PubMed ID: 9798303 [TBL] [Abstract][Full Text] [Related]
22. Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China. Ye N; Liu Z; Xu G; Wang X; Wu F; Xu X; Wu W Hematology; 2019 Dec; 24(1):631-636. PubMed ID: 31514689 [No Abstract] [Full Text] [Related]
23. First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin. Takeyama M; Nogami K; Kajimoto T; Ogiwara K; Matsumoto T; Shima M Int J Hematol; 2018 Jan; 107(1):112-116. PubMed ID: 28597369 [TBL] [Abstract][Full Text] [Related]
24. Immunosuppression Therapy in Acquired Hemophilia A: Pursuing an Optimal Regimen. Teixeira Passos D; Abrantes AM; Santos L; Cardoso A; Pais de Lacerda A Cureus; 2021 Dec; 13(12):e20467. PubMed ID: 35047291 [TBL] [Abstract][Full Text] [Related]
25. Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature. Sanges S; Jeanpierre E; Lopez B; Russick J; Delignat S; Carpentier B; Dubois R; Dubucquoi S; Guerrier T; Hachulla É; Hatron PY; Paris C; Susen S; Launay D; Lacroix-Desmazes S; Terriou L Front Immunol; 2020; 11():558811. PubMed ID: 33424828 [TBL] [Abstract][Full Text] [Related]
26. Relapse of Acquired Hemophilia A after COVID-19 Infection. Marumo A; Sugihara H; Omori I; Morishita E J Nippon Med Sch; 2024 Jan; 90(6):474-479. PubMed ID: 36823120 [TBL] [Abstract][Full Text] [Related]
27. Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission. Ogawa Y; Yanagisawa K; Naito C; Uchiumi H; Ishizaki T; Shimizu H; Gohda F; Ieko M; Ichinose A; Handa H Int J Hematol; 2020 Apr; 111(4):544-549. PubMed ID: 31939075 [TBL] [Abstract][Full Text] [Related]
28. Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled study. Zhang XH; Zhu XL; Niu T; Sun J; Liu H; Feng R; Yang LH; Wei Q; Ma QH; Wang QM; Feng FE; Fu HX; Mo XD; Lv M; Huang XJ Thromb Res; 2015 May; 135(5):835-40. PubMed ID: 25747536 [TBL] [Abstract][Full Text] [Related]
29. Idiopathic factor VIII inhibitor autoantibody in a man presented after accident. Mansouritorghabeh H; Lak M; van Heerde WL Clin Appl Thromb Hemost; 2009 Oct; 15(5):588-90. PubMed ID: 18550586 [TBL] [Abstract][Full Text] [Related]
30. Cross-reacting recombinant porcine FVIII inhibitors in patients with acquired haemophilia A. Bowyer A; Shepherd F; Platton S; Guy S; Kitchen S; Maclean R Haemophilia; 2020 Nov; 26(6):1181-1186. PubMed ID: 32997894 [TBL] [Abstract][Full Text] [Related]
31. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A. Pejsa V; Grgurević I; Kusec R; Gaćina P Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761 [TBL] [Abstract][Full Text] [Related]
32. Cross-reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH-AH 01/2010 Study. Türkantoz H; Königs C; Knöbl P; Klamroth R; Holstein K; Huth-Kühne A; Heinz J; Eichler H; Tiede A J Thromb Haemost; 2020 Jan; 18(1):36-43. PubMed ID: 31448877 [TBL] [Abstract][Full Text] [Related]
33. The use of porcine factor VIII in the treatment of patients with acquired hemophilia: the United Kingdom experience. Morrison AE; Ludlam CA Am J Med; 1991 Nov; 91(5A):23S-26S. PubMed ID: 1746592 [TBL] [Abstract][Full Text] [Related]
34. A Case Report of Idiopathic Acquired Hemophilia Type A. Amu-Hernández LA; Marzo-Alonso C; Tugues-Peiró A; Vicente-Pascual EP; Monteagudo-Aguilar P Cureus; 2023 May; 15(5):e38634. PubMed ID: 37284359 [TBL] [Abstract][Full Text] [Related]
35. International recommendations on the diagnosis and treatment of acquired hemophilia A. Tiede A; Collins P; Knoebl P; Teitel J; Kessler C; Shima M; Di Minno G; d'Oiron R; Salaj P; Jiménez-Yuste V; Huth-Kühne A; Giangrande P Haematologica; 2020 Jul; 105(7):1791-1801. PubMed ID: 32381574 [TBL] [Abstract][Full Text] [Related]
36. Acquired inhibitors of coagulation factors: part I-acquired hemophilia A. Coppola A; Favaloro EJ; Tufano A; Di Minno MN; Cerbone AM; Franchini M Semin Thromb Hemost; 2012 Jul; 38(5):433-46. PubMed ID: 22740182 [TBL] [Abstract][Full Text] [Related]
38. Acquired hemophilia A in a woman with systemic lupus erythematosus: A case report and review of literature. Shen P; Li J; Tu S; Chen G; Chen C Medicine (Baltimore); 2020 Oct; 99(43):e22926. PubMed ID: 33120848 [TBL] [Abstract][Full Text] [Related]
39. An extra X does not prevent acquired hemophilia - Pregnancy-associated acquired hemophilia A. Barg AA; Livnat T; Kenet G Thromb Res; 2017 Mar; 151 Suppl 1():S82-S85. PubMed ID: 28262242 [TBL] [Abstract][Full Text] [Related]
40. Rituximab in the treatment of acquired factor VIII inhibitors. Wiestner A; Cho HJ; Asch AS; Michelis MA; Zeller JA; Peerschke EI; Weksler BB; Schechter GP Blood; 2002 Nov; 100(9):3426-8. PubMed ID: 12384448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]